A major Japanese pharmaceutical company that offers therapies for rare diseases and operates around the globe has opened an ...

In early 2024, the World Health Organization predicted that by 2050 there will be more than 35 million new cancer cases ...

THE business delegation attending the five-day trade mission to Osaka, Japan, this February will have the opportunity to take ...

The rise in Biocon stock was also fuelled after Jefferies upgraded the stock to 'Buy', and raised the target to Rs 400 ...

-- Preliminary unaudited net revenues from global sales of IMCIVREE ® (setmelanotide) of approximately $42 million for the ...

Biocon added 3.69% to Rs 371.85 after the company said that Biocon Biologics has received approval from the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan for Ustekinumab BS subcutaneous ...

Dexcom forecast total annual revenue largely in line with Wall Street expectations on Monday, on bets there will be strong demand for its continuous glucose monitors for diabetes patients, sending the ...

Taiyo Holdings Co. is exploring a potential combination with larger peer DIC Corp. in a move that would consolidate two major ...

Kobe University will establish a new “Department of Medical Device Engineering” in April 2025 for the development of medical ...

JCR Pharmaceuticals Co., Ltd. (JP ... Newsletter JCR Pharmaceuticals has been granted orphan drug designation in Japan for JR-441, aimed at treating the rare Mucopolysaccharidosis Type IIIA.

all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter JCR Pharmaceuticals has been granted orphan drug designation in ...

Once confined to the province of abstract theory, quantum computing seeks to use operations based on quantum mechanics to ...